Deciphering the bone marrow microenvironment’s role in multiple myeloma immunotherapy resistance
Multiple Myeloma (MM) is a malignant monoclonal gammopathy characterized by the proliferation of plasma cells (PC) in the bone marrow (BM). The tight cross-talk between the BM microenvironment and PC is the hallmark of MM. The BM microenvironment comprises a cellular compartment, consisting of hemat...
Saved in:
| Main Authors: | Nicolas Thomas Iannozzi, Nicola Giuliani, Paola Storti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1613265/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis
by: Jinqiao Li, et al.
Published: (2024-12-01) -
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
by: Sina Kamrani, et al.
Published: (2025-03-01) -
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
by: Jahan Abdi, et al.
Published: (2025-03-01) -
Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives
by: Oxana Lungu, et al.
Published: (2025-04-01) -
CAR‐T cells in the treatment of multiple myeloma: an encouraging cell therapy
by: Tong Yu, et al.
Published: (2025-02-01)